Author:
Shao Xuejing,Liu Yujia,Li Yangling,Xian Miao,Zhou Qian,Yang Bo,Ying Meidan,He Qiaojun
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Coombs, C. C., Tavakkoli, M. & Tallman, M. S. Acute promyelocytic leukemia: where did we start, where are we now and the future. Blood cancer journal 5, e304 (2015).
2. Altucci, L. & Gronemeyer, H. The promise of retinoids to fight against cancer. Nat Rev Cancer 1, 181–193 (2001).
3. Takagi, S. et al. HER2 and HER3 cooperatively regulate cancer cell growth and determine sensitivity to the novel investigational EGFR/HER2 kinase inhibitor TAK-285. Oncoscience 1, 196–204 (2014).
4. Britten, C. D. Targeting ErbB receptor signaling: a pan-ErbB approach to cancer. Molecular cancer therapeutics 3, 1335–1342 (2004).
5. Corso, S. & Giordano, S. Targeted therapies in cancer and mechanisms of resistance. Journal of molecular medicine 92, 677–679 (2014).
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献